Indication
Sturge-Weber Syndrome
3 clinical trials
1 product
1 drug
Product
QLS-101Clinical trial
Pilot, Open-label Study of Safety and Tolerability of QLS-101 in Adolescents With Sturge-Weber Syndrome (SWS)-Related Glaucoma Due to Elevated Episcleral Venous Pressure (EVP)Status: Completed, Estimated PCD: 2023-01-25
Clinical trial
Masked, Randomized, Single-site, Crossover Study to Determine the Safety and Tolerability of 2 Concentrations of QLS-101 Dosed for 14 Days in Adult Subjects With Sturge-Weber Syndrome (SWS)-Related Glaucoma Due to Elevated Episcleral Venous Pressure (EVP)Status: Completed, Estimated PCD: 2022-06-06
Clinical trial
Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome: A Phase II TrialStatus: Completed, Estimated PCD: 2021-08-16
Drug
cannabidiol